CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
Cancer Research Institute · UPMC Hillman Cancer Center · +2 more institutions
Abstract
CTLA-4 and PD-1 are receptors that negatively regulate T-cell activation. Ligation of both CTLA-4 and PD-1 blocked CD3/CD28-mediated upregulation of glucose metabolism and Akt activity, but each accomplished this regulation using separate mechanisms. CTLA-4-mediated inhibition of Akt phosphorylation is sensitive to okadaic acid, providing direct evidence that PP2A plays a prominent role in mediating CTLA-4 suppression of T-cell activation. In contrast, PD-1 signaling inhibits Akt phosphorylation by preventing CD28-mediated activation of phosphatidylinositol 3-kinase (PI3K). The ability of PD-1 to suppress PI3K/AKT activation was dependent upon the immunoreceptor tyrosine-based switch motif located in its…
Citation impact
- FWCI
- 6.83
- Percentile
- 100%
- References
- 73
Authors
9- RVRichard V. Parry
Cancer Research Institute, UPMC Hillman Cancer Center, University of Pennsylvania
- JMJens M. Chemnitz
Cancer Research Institute, UPMC Hillman Cancer Center, University of Pennsylvania
- KAKenneth A. Frauwirth
Cancer Research Institute, UPMC Hillman Cancer Center, University of Pennsylvania
- ARAnthony R. Lanfranco
Cancer Research Institute, UPMC Hillman Cancer Center, University of Pennsylvania
- IBInbal Braunstein
Cancer Research Institute, UPMC Hillman Cancer Center, University of Pennsylvania
Topics & keywords
- Biology
- Phosphorylation
- Cell biology
- CD28
- Protein kinase B
- PI3K/AKT/mTOR pathway
- Signal transduction
- T-cell receptor